B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice
- PMID: 1924323
- PMCID: PMC52560
- DOI: 10.1073/pnas.88.19.8616
B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice
Abstract
The genes encoding the heavy- and light-chain Fv regions of the monoclonal murine antibody B3, which recognizes a carbohydrate antigen on the surface of many human carcinomas, were cloned by PCR techniques and used to generate single-chain immunotoxins containing Pseudomonas exotoxin (PE). The light and heavy chains were connected by a flexible linker to form a single-chain antigen-binding protein, B3(Fv), which was in turn fused to truncated forms of PE lacking the cell-binding domain. The single-chain Fv and two different B3(Fv) immunotoxins, B3(Fv)-PE40 and B3(Fv)-PE38KDEL, were expressed in Escherichia coli and the single-chain immunotoxins were purified to near homogeneity. Both recombinant immunotoxins were shown to be cytotoxic specifically to carcinoma cell lines that express the B3 antigen on their surface; B3(Fv)-PE38KDEL was significantly more active. Furthermore, intravenous administration of B3(Fv)-PE38KDEL caused complete regression of human epidermoid carcinomas growing subcutaneously in immunodeficient mice.
Similar articles
-
Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.J Immunol. 1993 Apr 1;150(7):2774-82. J Immunol. 1993. PMID: 8454854
-
Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.Int J Cancer. 1996 Jul 3;67(1):113-23. doi: 10.1002/(SICI)1097-0215(19960703)67:1<113::AID-IJC19>3.0.CO;2-F. Int J Cancer. 1996. PMID: 8690511
-
Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3.J Biol Chem. 1995 Oct 6;270(40):23373-80. doi: 10.1074/jbc.270.40.23373. J Biol Chem. 1995. PMID: 7559495
-
Recombinant single-chain immunotoxins against T and B cell leukemias.Leuk Lymphoma. 1994 Mar;13(1-2):1-10. Leuk Lymphoma. 1994. PMID: 8025511 Review.
-
Targeted therapy of carcinomas using BR96 sFv-PE40, a single-chain immunotoxin that binds to the Le(y) antigen.Semin Cancer Biol. 1995 Oct;6(5):289-95. doi: 10.1006/scbi.1995.0037. Semin Cancer Biol. 1995. PMID: 8562906 Review.
Cited by
-
Targeted toxins in brain tumor therapy.Toxins (Basel). 2010 Nov;2(11):2645-62. doi: 10.3390/toxins2112645. Epub 2010 Nov 1. Toxins (Basel). 2010. PMID: 22069569 Free PMC article. Review.
-
Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein.Mol Med. 1998 Jun;4(6):384-91. Mol Med. 1998. PMID: 10780881 Free PMC article.
-
Bispecific digoxigenin-binding antibodies for targeted payload delivery.Proc Natl Acad Sci U S A. 2011 May 17;108(20):8194-9. doi: 10.1073/pnas.1018565108. Epub 2011 May 2. Proc Natl Acad Sci U S A. 2011. PMID: 21536919 Free PMC article.
-
Recombinant antibodies for the diagnosis and treatment of cancer.Mol Biotechnol. 2003 Sep;25(1):1-17. doi: 10.1385/MB:25:1:1. Mol Biotechnol. 2003. PMID: 13679630 Review.
-
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome.Cancer Immunol Immunother. 2007 Nov;56(11):1775-83. doi: 10.1007/s00262-007-0321-4. Epub 2007 Apr 13. Cancer Immunol Immunother. 2007. PMID: 17431617 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources